Latest Articles
Precision Medicine May Be on the Way for Patients with Endometriosis - Yale School of Medicine
Precision Medicine May Be on the Way for Patients with Endometriosis Yale School of Medicine
Published: March 20, 2026, 1:19 p.m.
Patient questions limited access to IWK's endometriosis clinic as wait times grow - CBC
Patient questions limited access to IWK's endometriosis clinic as wait times grow CBC
Published: March 20, 2026, 9 a.m.
Endometriosis Crisis Demands Global Attention as Patients Lead Reform - streamlinefeed.co.ke
Endometriosis Crisis Demands Global Attention as Patients Lead Reform streamlinefeed.co.ke
Published: March 20, 2026, 7:50 a.m.
Artificial Intelligence Leads Endometriosis Patient to a Diagnosis After 12 Years of Pain and Suffering - Endometriosis Foundation of America
Artificial Intelligence Leads Endometriosis Patient to a Diagnosis After 12 Years of Pain and Suffering Endometriosis Foundation of America
Published: March 19, 2026, 6:18 p.m.
Some Endometriosis Patients Are Changing Their Diets to Manage Symptoms - Rewire News Group
Some Endometriosis Patients Are Changing Their Diets to Manage Symptoms Rewire News Group
Published: March 19, 2026, 2:12 p.m.
First patient dosed in Gesynta Pharma's phase II trial in endometriosis - Biostock
First patient dosed in Gesynta Pharma's phase II trial in endometriosis Biostock
Published: March 18, 2026, 11:33 a.m.
Gesynta Pharma doses first patient in Phase II NOVA trial - MSN
Gesynta Pharma doses first patient in Phase II NOVA trial MSN
Published: March 17, 2026, 6:25 p.m.
Weekly review: Preserving fertility in patients with cancer; GSL, and high stroke risk in pregnancy - Contemporary OB/GYN
Weekly review: Preserving fertility in patients with cancer; GSL, and high stroke risk in pregnancy Contemporary OB/GYN
Published: March 16, 2026, 2:41 p.m.
'More needs to be done' for endometriosis patients, says health minister - MSN
'More needs to be done' for endometriosis patients, says health minister MSN
Published: March 13, 2026, 3:45 a.m.
Gesynta Pharma doses first patient in Phase II NOVA trial - World Pharmaceutical Frontiers
Gesynta Pharma doses first patient in Phase II NOVA trial World Pharmaceutical Frontiers
Published: March 12, 2026, 11:13 a.m.
Link copied to clipboard!